Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ruffolo

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptorsJ P Hieble, A C Sulpizio, A J Nichols, et al.
Atherosclerosis|December 11, 1992
Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copperT L Yue, P J McKenna, P G Lysko, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activityM Gellai, G F Schreiner, R R Ruffolo, et al.
Pharmacotherapy|January 1, 1990
Dobutamine vs dopamine: another lookJ F Dasta, J L Bauman, L H Danziger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078R R Ruffolo, A C Sulpizio, A J Nichols, et al.
European Journal of Pharmacology|May 21, 1998
Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heartT L Yue, X L Ma, J L Gu, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 1991
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058D P Brooks, M P Mitchell, B G Short, et al.
Pharmacology|January 1, 1989
In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilolA J Nichols, A C Sulpizio, D J Ashton, et al.
Pharmacology|February 19, 1998
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heartR N Willette, M P Mitchell, E H Ohlstein, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptorsJ P Hieble, A C Sulpizio, A J Nichols, et al.
Atherosclerosis|December 11, 1992
Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copperT L Yue, P J McKenna, P G Lysko, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activityM Gellai, G F Schreiner, R R Ruffolo, et al.
Pharmacotherapy|January 1, 1990
Dobutamine vs dopamine: another lookJ F Dasta, J L Bauman, L H Danziger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078R R Ruffolo, A C Sulpizio, A J Nichols, et al.
European Journal of Pharmacology|May 21, 1998
Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heartT L Yue, X L Ma, J L Gu, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitorsD P Brooks, P D DePalma, T A Fredrickson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 1991
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058D P Brooks, M P Mitchell, B G Short, et al.
Pharmacology|January 1, 1989
In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilolA J Nichols, A C Sulpizio, D J Ashton, et al.
Pharmacology|February 19, 1998
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heartR N Willette, M P Mitchell, E H Ohlstein, et al.
Pageof 23